388
Views
1
CrossRef citations to date
0
Altmetric
Review

Emerging drugs for the treatment of triple-negative breast cancer: a focus on phase II immunotherapy trials

ORCID Icon &
Pages 131-147 | Received 13 Dec 2020, Accepted 09 Apr 2021, Published online: 19 Apr 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Eileen Stoll, Michael Hader, Michael Rückert, Thomas Weissmann, Sebastian Lettmaier, Florian Putz, Markus Hecht, Rainer Fietkau, Andreas Rosin, Benjamin Frey & Udo S. Gaipl. (2022) Detailed in vitro analyses of the impact of multimodal cancer therapy with hyperthermia and radiotherapy on the immune phenotype of human glioblastoma cells. International Journal of Hyperthermia 39:1, pages 796-805.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.